authors
- Dodge, Hiroko H
- Zhu, Jian
- Harvey, Danielle
- Saito, Naomi
- Lisa Silbert, MD, MCR
- Kaye, Jeffrey A
- Koeppe, Robert A
- Albin, Roger L
Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2014
published in
has subject area
- Aged
- Aged, 80 and over
- Alzheimer Disease
- Biomarkers
- Cognition Disorders
- Databases, Factual
- Disease Progression
- Executive Function
- Female
- Fluorodeoxyglucose F18
- Humans
- Longitudinal Studies
- Magnetic Resonance Imaging
- Male
- Memory
- Mental Status Schedule
- Neuropsychological Tests
- Positron-Emission Tomography